Daily news email for July 19, 2010 | Click here for updated news
SourceSolution News
New reporting features added to the Supplier Relationship Management system. Sign up here for our daily webinar to learn more.
Search over 86,000 clinical trials by phase of development and indication at www.sourcesolution.com
PlanIt client portal software lets you exchange and track documents, manage budgets and assign tasks. 3 day implementation!
|
BioSpace
New Genentech Bevacizumab Data Fails to Support Use in Advanced Breast Cancer
Richmond, Virginia Could Spend $650,000 to Keep Pfizer Inc.
Treating HIV Also Prevents Its Spread, Study Finds
Amgen Gets Priority Review For Prolia
Gilead Sciences, Inc. Vaginal Gel Study Charts New Course for HIV Prevention; Test Results Released Tomorrow
|
BioSpace - Breaking News
Tobira Therapeutics Inc.'s Next-Generation Once-Daily CCR5/CCR2 Antagonist Demonstrates Potent CCR2 Inhibition, Antiviral Activity, Safety and Tolerability in Treatment-Experienced Patients With HIV
Argos Therapeutics, Inc.' Arcelis(TM) HIV Immunotherapy Demonstrates Significant Reduction in Viral Load and Delay in Viral Rebound Kinetics in Interim Analysis of Phase 2 Study
Mylan Inc. Receives Approval for Generic Version of Catapres-TTS(R)
FDA Grants Priority Review Designation to Amgen's Denosumab Biologics License Application for the Reduction of Skeletal Related Events in Advanced Cancer Patients
PriCara, Ortho-McNeil-Janssen Pharmaceuticals, Inc.: Phase 3 Open-Label Study Comparing Tapentadol Extended Release Tablets to Oxycodone Controlled Release Tablets Published by
|
